Anti-Hypertensive Drugs Global Market Report 2023

Feb 2023| TBR513E| TBRC (Publisher)

Sample Report

Report Highlights

Including: 1) By Therapeutics: Diuretics; Angiotensin Receptor Blockers (ARBs); Angiotensin Converting Enzyme (ACE) Inhibitors; Beta Blockers; Alpha Blockers; Calcium Channel Blockers; Renin Inhibitors; Vasodilators
2) By Disease Source: Primary Hypertension; Secondary Hypertension
3) By End Users: Hospitals; Clinics; Homecare
Covering: Merck & Co. Inc.; Astra Zeneca Plc; Daiichi Sankyo Company Limited; Johnson & Johnson Ltd.; Pfizer Inc.

Anti-Hypertensive Drugs Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti-hypertensive drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for anti-hypertensive drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-hypertensive drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Synopsis

Report Metrics	Details
Base year considered	2022
Forecast period considered	2022-2032
Units considered	$ Billion
Segments covered	By Therapeutics, By Disease Source, By End Users
Industry covered	Pharmaceuticals
Regions covered	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered	Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Companies studied	Merck & Co. Inc.; Bayer AG; Astra Zeneca Plc; Daiichi Sankyo Company Limited; Johnson & Johnson Ltd.; Pfizer Inc.; Novartis AG; Sanofi SA; United Therapeutics; Ranbaxy Laboratories; Abbott; Lupin Limited; Boehringer Engelheim GmbH; Bayer AG; Sun Pharmaceuticals LLC; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Roche; Actelion; Gilead; Teva Pharmaceutical Industries Ltd.

Scope

Markets Covered:

By Therapeutics: Diuretics; Angiotensin Receptor Blockers (ARBs); Angiotensin Converting Enzyme (ACE) Inhibitors; Beta Blockers; Alpha Blockers; Calcium Channel Blockers; Renin Inhibitors; Vasodilators
By Disease Source: Primary Hypertension; Secondary Hypertension
By End Users: Hospitals; Clinics; Homecare

Companies Mentioned: Merck & Co. Inc.; Astra Zeneca Plc; Daiichi Sankyo Company Limited; Johnson & Johnson Ltd.; Pfizer Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3 : Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4 : Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5 : Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6 : Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7 : Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8 : Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9 : Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10 : China, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11 : China, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12 : India, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13 : India, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14 : Japan, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15 : Japan, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16 : Australia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17 : Australia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18 : Indonesia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19 : Indonesia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20 : South Korea, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21 : South Korea, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22 : Western Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23 : Western Europe, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24 : UK, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25 : UK, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26 : Germany, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27 : Germany, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 28 : France, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 29 : France, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 30 : Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 31 : Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 32 : Russia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 33 : Russia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 34 : North America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 35 : North America, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 36 : USA, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 37 : USA, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 38 : South America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 39 : South America, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 40 : Brazil, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 41 : Brazil, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 42 : Middle East, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 43 : Middle East, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 44 : Africa, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 45 : Africa, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46 : Merck & Co. Inc. Financial Performance
Table 47 : Astra Zeneca Plc Financial Performance
Table 48 : Daiichi Sankyo Company Limited Financial Performance
Table 49 : Johnson & Johnson Ltd. Financial Performance
Table 50 : Pfizer, Inc. Financial Performance

Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3 : Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4 : Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5 : Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6 : Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7 : Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8 : Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9 : Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10 : China, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11 : China, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12 : India, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13 : India, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14 : Japan, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15 : Japan, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16 : Australia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17 : Australia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18 : Indonesia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19 : Indonesia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20 : South Korea, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21 : South Korea, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22 : Western Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23 : Western Europe, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24 : UK, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25 : UK, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26 : Germany, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27 : Germany, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 28 : France, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 29 : France, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 30 : Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 31 : Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 32 : Russia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 33 : Russia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 34 : North America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 35 : North America, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 36 : USA, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 37 : USA, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 38 : South America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 39 : South America, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 40 : Brazil, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 41 : Brazil, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 42 : Middle East, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 43 : Middle East, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 44 : Africa, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 45 : Africa, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 46 : Merck & Co. Inc. Financial Performance
Figure 47 : Astra Zeneca Plc Financial Performance
Figure 48 : Daiichi Sankyo Company Limited Financial Performance
Figure 49 : Johnson & Johnson Ltd. Financial Performance
Figure 50 : Pfizer, Inc. Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Anti-Hypertensive Drugs Global Market Report 2022

Published Date - Mar 2022
Report Code - TBR513D

Including: 1) By Therapeutics: Diuretics; Angiotensin Receptor Blockers (ARBs); Angiotensin Converting Enzyme (ACE) Inhibitors; Beta Blockers; Alpha Blockers; Calcium Channel Blockers; Renin Inhibitors; Vasodilators
2) By Disease Source: Primary Hypertension; Secondary Hypertension
3) By End Users: Hospitals; Clinics; Homecare
Covering: Merck & Co. Inc.; Astra Zeneca Plc.; Daiichi Sankyo Company Limited; Johnson & Johnson Ltd.; Pfizer Inc.

Anti-Hypertensive Drugs Global ...

Anti-Hypertensive Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

Published Date - Jun 2021
Report Code - TBR513C

Including: 1) By Therapeutics: Diuretics; Angiotensin Receptor Blockers (ARBs); Angiotensin Converting Enzyme (ACE) Inhibitors; Beta Blockers; Alpha Blockers; Calcium Channel Blockers; Renin Inhibitors; Vasodilators
2) By Disease source: Primary Hypertension; Secondary Hypertension
3) By End users: Hospitals; Clinics; Homecare

Covering: Merck & Co.; Astra Zeneca Plc; Daiichi Sankyo Company Limited; Johnson & Johnson Ltd.; Pfizer

Anti-Hypertensive Drugs G from The ...

Anti-Hypertensive Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

Published Date - Sep 2020
Report Code - TBR513B